2,684
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Curcumin suppresses inflammatory cytokines and heat shock protein 70 release and improves metabolic parameters during experimental sepsis

, , , , , & show all
Pages 269-276 | Received 12 Feb 2016, Accepted 09 Nov 2016, Published online: 07 Dec 2016

References

  • Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. 2007. Bioavailability of curcumin: problems and promises. Mol Pharm. 4:807–818.
  • Basnet P, Skalko-Basnet N. 2011. Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules. 16:4567–4598.
  • Bone RC, Grodzin CJ, Balk RA. 1997. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest. 112:235–243.
  • Bozza FA, Salluh JI, Japiassu AM, Soares M, Assis EF, Gomes RN, Bozza MT, Castro-Faria-Neto HC, Bozza PT. 2007. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care. 11:R49
  • Buhrmann C, Mobasheri A, Busch F, Aldinger C, Stahlmann R, Montaseri A, Shakibaei M. 2011. Curcumin modulates nuclear factor kappaB (NF-kappaB)-mediated inflammation in human tenocytes in vitro: role of the phosphatidylinositol 3-kinase/Akt pathway. J Biol Chem. 286:28556–28566.
  • Burgos-Moron E, Calderon-Montano JM, Salvador J, Robles A, Lopez-Lazaro M. 2010. The dark side of curcumin. Int J Cancer. 126:1771–1775.
  • Cavaillon JM, Adib-Conquy M, Fitting C, Adrie C, Payen D. 2003. Cytokine cascade in sepsis. Scand J Infect Dis. 35:535–544.
  • Chen HW, Kuo HT, Wang SJ, Lu TS, Yang RC. 2005. In vivo heat shock protein assembles with septic liver NF-kappaB/I-kappaB complex regulating NF-kappaB activity. Shock. 24:232–238.
  • Correa PB, Pancoto JA, de Oliveira-Pelegrin GR, Carnio EC, Rocha MJ. 2007. Participation of iNOS-derived NO in hypothalamic activation and vasopressin release during polymicrobial sepsis. J Neuroimmunol. 183:17–25.
  • Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, et al. 2008. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 36:296–327.
  • Dunsmore KE, Chen PG, Wong HR. 2001. Curcumin, a medicinal herbal compound capable of inducing the heat shock response. Crit Care Med. 29:2199–2204.
  • Erusalimsky JD, Moncada S. 2007. Nitric oxide and mitochondrial signaling: from physiology to pathophysiology. Arterioscler Thromb Vasc Biol. 27:2524–2531.
  • Faix JD. 2013. Biomarkers of sepsis. Crit Rev Clin Lab Sci. 50:23–36.
  • Figueiredo MJ, Soares DM, Martins JM, Machado Rde R, Sorgi CA, Faccioli LH, Melo MC, Malvar Ddo C, Souza GE. 2012. Febrile response induced by cecal ligation and puncture (CLP) in rats: involvement of prostaglandin E2 and cytokines. Med Microbiol Immunol. 201:219–229.
  • Fishel RS, Are C, Barbul A. 2003. Vessel injury and capillary leak. Crit Care Med. 31:S502–S511.
  • Frink M, van Griensven M, Kobbe P, Brin T, Zeckey C, Vaske B, Krettek C, Hildebrand F. 2009. IL-6 predicts organ dysfunction and mortality in patients with multiple injuries. Scand J Trauma Resusc Emerg Med. 27:17–49.
  • Fujiwara H, Hosokawa M, Zhou X, Fujimoto S, Fukuda K, Toyoda K, Nishi Y, Fujita Y, Yamada K, Yamada Y, et al. 2008. Curcumin inhibits glucose production in isolated mice hepatocytes. Diabetes Res Clin Pract. 80:185–191.
  • Gelain DP, de Bittencourt Pasquali MA, M Comim C, Grunwald MS, Ritter C, Tomasi CD, Alves SC, Quevedo J, Dal-Pizzol F, Moreira JC. 2011. Serum heat shock protein 70 levels, oxidant status, and mortality in sepsis. Shock. 35:466–470.
  • Gonsalves MD, Sakr Y. 2010. Early identification of sepsis. Curr Infect Dis Rep. 12:329–335.
  • Gupta SC, Prasad S, Kim JH, Patchva S, Webb LJ, Priyadarsini IK, Aggarwal BB. 2011. Multitargeting by curcumin as revealed by molecular interaction studies. Nat Prod Rep. 28:1937–1955.
  • Jean-Baptiste E. 2007. Cellular mechanisms in sepsis. J Intensive Care Med. 22:63–72.
  • Joly AL, Wettstein G, Mignot G, Ghiringhelli F, Garrido C. 2010. Dual role of heat shock proteins as regulators of apoptosis and innate immunity. J Innate Immun. 2:238–247.
  • Jurenka JS. 2009. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern Med Rev. 14:141–153.
  • Kregel KC. 2002. Heat shock proteins: modifying factors in physiological stress responses and acquired thermotolerance. J Appl Physiol. 92:2177–2186.
  • Kumar A, Thota V, Dee L, Olson J, Uretz E, Parrillo JE. 1996. Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med. 183:949–958.
  • Ma Z, Shayeganpour A, Brocks DR, Lavasanifar A, Samuel J. 2007. High-performance liquid chromatography analysis of curcumin in rat plasma: application to pharmacokinetics of polymeric micellar formulation of curcumin. Biomed Chromatogr. 21:546–552.
  • Mancuso C, Barone E. 2009. Curcumin in clinical practice: myth or reality?. Trends Pharmacol Sci. 30:333–334.
  • Marik PE, Raghavan M. 2004. Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med. 30:748–756.
  • Memis D, Hekimoglu S, Sezer A, Altaner S, Sut N, Usta U. 2008. Curcumin attenuates the organ dysfunction caused by endotoxemia in the rat. Nutrition. 24:1133–1138.
  • Mendonca LM, da Silva Machado C, Teixeira CC, de Freitas LA, Bianchi Mde L, Antunes LM. 2013. Curcumin reduces cisplatin-induced neurotoxicity in NGF-differentiated PC12 cells. Neurotoxicology. 34:205–211.
  • Mendonca LM, Machado Cda S, Teixeira CC, Freitas LA, Bianchi ML, Antunes LM. 2015. Comparative study of curcumin and curcumin formulated in a solid dispersion: Evaluation of their antigenotoxic effects. Genet Mol Biol. 38:490–498.
  • Nduka OO, Parrillo JE. 2011. The pathophysiology of septic shock. Crit Care Nurs Clin North Am. 23:41–66.
  • Nemzek JA, Xiao HY, Minard AE, Bolgos GL, Remick DG. 2004. Humane endpoints in shock research. Shock. 21:17–25.
  • Njemini R, Demanet C, Mets T. 2004. Inflammatory status as an important determinant of heat shock protein 70 serum concentrations during aging. Biogerontology. 5:31–38.
  • Njemini R, Bautmans I, Onyema OO, Van Puyvelde K, Demanet C, Mets T. 2011. Circulating heat shock protein 70 in health, aging and disease. BMC Immunol. 12:24–24.
  • Norbury WB, Jeschke MG, Herndon DN. 2007. Metabolism modulators in sepsis: propranolol. Crit Care Med. 35:S616–S620.
  • Oliveira-Pelegrin GR, Aguila FA, Basso PJ, Rocha MJ. 2010. Role of central NO-cGMP pathway in vasopressin and oxytocin gene expression during sepsis. Peptides. 31:1847–1852.
  • Oliveira-Pelegrin GR, Basso PJ, Soares AS, Martinez MR, Riester KD, Rocha MJ. 2013. Cleaved caspase-3 expression in hypothalamic magnocellular neurons may affect vasopressin secretion during experimental polymicrobial sepsis. J Neuroimmunol. 258:10–16.
  • Poylin V, Fareed MU, O'Neal P, Alamdari N, Reilly N, Menconi M, Hasselgren PO. 2008. The NF-kappaB inhibitor curcumin blocks sepsis-induced muscle proteolysis. Mediators Inflamm. 2008:317851
  • Rittirsch D, Huber-Lang MS, Flierl MA, Ward PA. 2009. Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc. 4:31–36.
  • Salas MA, Evans SW, Levell MJ, Whicher JT. 1990. Interleukin-6 and ACTH act synergistically to stimulate the release of corticosterone from adrenal gland cells. Clin Exp Immunol. 79:470–473.
  • Sandur SK, Ichikawa H, Pandey MK, Kunnumakkara AB, Sung B, Sethi G, Aggarwal BB. 2007. Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane). Free Radic Biol Med. 43:568–580.
  • Seehofer D, Schirmeier A, Bengmark S, Cho SY, Koch M, Lederer A, Rayes N, Menger MD, Neuhaus P, Nüssler AK. 2010. Curcumin attenuates oxidative stress and inflammatory response in the early phase after partial hepatectomy with simultaneous intraabdominal infection in rats. J Surg Res. 159:497–502.
  • Siddiqui AM, Cui X, Wu R, Dong W, Zhou M, Hu M, Simms HH, Wang P. 2006. The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-gamma. Crit Care Med. 34:1874–1882.
  • Singh U, Barik A, Singh BG, Priyadarsini KI. 2011. Reactions of reactive oxygen species (ROS) with curcumin analogues: Structure-activity relationship. Free Radic Res. 45:317–325.
  • Song Y, Ge W, Cai H, Zhang H. 2013. Curcumin protects mice from coxsackievirus B3-induced myocarditis by inhibiting the phosphatidylinositol 3 kinase/Akt/nuclear factor-κB pathway. J Cardiovasc Pharmacol Ther. 18:560–569.
  • Soobrattee MA, Neergheen VS, Luximon-Ramma A, Aruoma OI, Bahorun T. 2005. Phenolics as potential antioxidant therapeutic agents: mechanism and actions. Mutat Res. 579:200–213.
  • Sreejayan Rao MN. 1994. Curcuminoids as potent inhibitors of lipid peroxidation. J Pharm Pharmacol. 46:1013–1016.
  • Szabo C. 1995. Alterations in nitric oxide production in various forms of circulatory shock. New Horiz. 3:2–32.
  • Teixeira CC, Mendonça LM, Bergamaschi MM, Queiroz RH, Souza GE, Antunes LM, Freitas LA. 2016. Microparticles containing curcumin solid dispersion: stability, bioavailability and anti-inflammatory activity. AAPS Pharm Sci Tech. 17:252–261.
  • Thiemermann C. 1997. Nitric oxide and septic shock. Gen Pharmacol. 29:159–166.
  • Tsai YM, Chien C, Lin LC, Tsai TH. 2011. Curcumin and its nano-formulation: the kinetics of tissue distribution and blood-brain barrier penetration. Int J Pharm. 416:331–338.
  • Tschaikowsky K, Hedwig-Geissing M, Braun GG, Radespiel-Troeger M. 2011. Predictive value of procalcitonin, interleukin-6, and C-reactive protein for survival in postoperative patients with severe sepsis. J Crit Care. 26:54–64.
  • Vachharajani V, Wang SW, Mishra N, El Gazzar M, Yoza B, McCall C. 2010. Curcumin modulates leukocyte and platelet adhesion in murine sepsis. Microcirculation. 17:407–416.
  • Vincent JL, Korkut HA. 2008. Defining sepsis. Clin Chest Med. 29:585–590.
  • Wahab F, Tazinafo LF, Cárnio EC, Aguila FA, Batalhão ME, Rocha MJ. 2015. Interleukin-1 receptor antagonist decreases cerebrospinal fluid nitric oxide levels and increases vasopressin secretion in the late phase of sepsis in rats. Endocrine. 49:215–221.
  • Wong HR, Salisbury S, Xiao Q, Cvijanovich NZ, Hall M, Allen GL, Thomas NJ, Freishtat RJ, Anas N, Meyer K, et al. 2012. The pediatric sepsis biomarker risk model. Crit Care. 16:R174
  • Wong HR, Weiss SL, Giuliano JS, Jr, Wainwright MS, Cvijanovich NZ, Thomas NJ, Allen GL, Anas N, Bigham MT, Hall M, et al. 2014. Testing the prognostic accuracy of the updated pediatric sepsis biomarker risk model. PLoS One. 29:e86242.
  • Xiao X, Yang M, Sun D, Sun S. 2012. Curcumin protects against sepsis-induced acute lung injury in rats. J Surg Res. 176:e31–e39.
  • Yang C, Su X, Liu A, Zhang L, Yu A, Xi Y, Zhai G. 2013. Advances in clinical study of curcumin. Curr Pharm Des. 19:1966–1973.
  • Yilmaz Savcun G, Ozkan E, Dulundu E, Topaloğlu U, Sehirli AO, Tok OE, Ercan F, Sener G. 2013. Antioxidant and anti-inflammatory effects of curcumin against hepatorenal oxidative injury in an experimental sepsis model in rats. Ulus Travma Acil Cerrahi Derg. 19:507–515.
  • Ziegler TR, Ogden LG, Singleton KD, Luo M, Fernandez-Estivariz C, Griffith DP, Galloway JR, Wischmeyer P. 2005. Parenteral glutamine increases serum heat shock protein 70 in critically ill patients. Intensive Care Med. 31:1079–1086.